Catherine Skari

NEW TIF PUBLICATIONS | From Everyday Questions to Emergency Care

Understanding treatment, preparing for appointments and planning for the future are important parts of living with thalassaemia. When urgent health…

Read More »

CONGENITAL DYSERYTHROPOIETIC ANAEMIA | New Study Highlights Endocrine Complications

Researchers reviewed the records of 12 patients aged 6–49 years. Nine had endocrine abnormalities, including low bone mineral density, diabetes,…

Read More »

TIF Annual General Assembly & Capacity Building Workshop 20–22 November 2026 | Athens, Greece

From 20 to 22 November 2026, the Thalassaemia International Federation (TIF) will convene its Annual General Assembly (AGA) and Capacity…

Read More »

THE MENA THALASSAEMIA EXPERIENCE | 30–31 October 2026

IMPORTANT UPDATE: Due to the ongoing situation in the Middle East, and with the safety and well-being of participants, faculty…

Read More »

Efficacy and Safety οf Mitapivat in Adults with Transfusion-Dependent Α-Thalassaemia or Β-Thalassaemia (ENERGIZE-T): A Double-Blind, Randomised, Multicentre, Placebo-Controlled, Phase 3 Trial

Abstract Background: The absence of disease-modifying therapies for patients with α-thalassaemia and oral disease-modifying therapies for patients with β-thalassaemia has been…

Read More »

Delayed Recognition and Significant Morbidity in Adults with Non-Transfusion-Dependent Thalassemia

Abstract: Non-transfusion-dependent thalassemia (NTDT) is characterized by variable degrees of anemia, ineffective erythropoiesis, and iron overload, with a heightened risk…

Read More »

Global Burden of Thalassemia by Socio-Demographic Index, 1990–2023: Trends, Disparities, and Future Implications

Thalassemia imposes a substantial and unequal global health burden, yet its temporal evolution stratified by sociodemographic development remains incompletely characterized…

Read More »

EHA Recommendations for Preconceptual and Antenatal Screening and Prenatal Diagnosis for Hemoglobinopathies

Abstract Thalassemia and sickle cell disease (SCD) are among the most common monogenic disorders worldwide. They cause chronic hemolytic anemia,…

Read More »

In Utero Hematopoietic Cell Transplantation in Fetuses With Α-Thalassemia Major: A Phase 1 Clinical Trial

Abstract In utero hematopoietic cell transplantation (IUHCT) has the potential to treat patients who have hemoglobinopathies by harnessing the unique…

Read More »